Incidence of second primary malignancies in patients with treated head and neck cancer: a comprehensive review of literature
- 23 November 2012
- journal article
- review article
- Published by Informa Healthcare in Current Medical Research and Opinion
- Vol. 28 (12) , 1899-1909
Abstract
(2012). Incidence of second primary malignancies in patients with treated head and neck cancer: a comprehensive review of literature. Current Medical Research and Opinion: Vol. 28, No. 12, pp. 1899-1909. doi: 10.1185/03007995.2012.746218Keywords
This publication has 57 references indexed in Scilit:
- Genetic variants of p27 and p21 as predictors for risk of second primary malignancy in patients with index squamous cell carcinoma of head and neckMolecular Cancer, 2012
- Practical Considerations in the Re-Irradiation of Recurrent and Second Primary Head-and-Neck Cancer: Who, Why, How, and How Much?International Journal of Radiation Oncology - Biology - Physics (IJROBP), 2011
- Current concepts of surveillance and its significance in head and neck cancerThe Annals of The Royal College of Surgeons of England, 2011
- Genetic sequence variants and the development of secondary primary cancers in patients with head and neck cancersCancer, 2011
- Anatomic sites at elevated risk of second primary cancer after an index head and neck cancerCancer Causes & Control, 2011
- Chemoprevention of Head and Neck Cancer by Green Tea Extract: EGCG—The Role of EGFR Signaling and “Lipid Raft”Journal of Oncology, 2011
- Second primary lung malignancy in head and neck cancer patientsEuropean Annals of Otorhinolaryngology, Head and Neck Diseases, 2011
- High constant incidence rates of second primary cancers of the head and neck: A pooled analysis of 13 cancer registriesInternational Journal of Cancer, 2010
- Chemoprevention of Head and Neck Cancer with Green Tea PolyphenolsCancer Prevention Research, 2010
- The incidence and risk of developing a second primary esophageal cancer in patients with oral and pharyngeal carcinoma: a population-based study in Taiwan over a 25 year periodBMC Cancer, 2009